🔗 Share this article

An underground market for unlicensed slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Experimental Treatment Gaining Popularity Online

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Viewers are urged to contact these accounts directly for source information, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a robust trade exists on Telegram, where communities with thousands of participants share “before and after” images, administration instructions and assertions of next-day British shipping. Vendors promote the drug there before directing customers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Professionals Express Concerns

Nevertheless, physicians and chemists have cautions that the distribution of what remains an unlicensed medication in the UK is worrisome and could result in individuals injecting substances of uncertain source.

Several professionals stated the demand for retatrutide could be linked to the rising price of approved weight loss products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or supplied for human use under the British medical regulations.

Some influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach medicines, advertising, and customer regulations, potentially leading to fines, legal action or imprisonment.

Platform Reaction and Content Removal

Based on TikTok, the service has removed problematic content and prohibited associated hashtags and search suggestions. The company said it was dedicated to maintaining the service secure and allocating resources in strengthening compliance measures.

Digital Trading Activities

Research also found groups with up to nine thousand members selling the experimental drug using Telegram's integrated search feature, which functions like a online catalog. Entering “retatrutide” instantly displays channels with numerous of users, populated with photos of slimming results, positive reviews and step-by-step guides for mixing or administering at home.

After moments of entering one community, a seller shared WhatsApp details, where most transactions occur. The seller provided an guidebook and promised shipping within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about body mass, medical conditions or previous experience.

Item Details and Costs

Inside these groups, posts display black plastic parcels with postal service stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with sterile water, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When questioned how long a injector should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for Telegram stated it actively moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting substances they can’t verify. Even if the science behind this drug is sound, these online products may not include what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current price rises for approved slimming medications such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit injections are highly risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she explained.

Her staff has previously seen patients harmed by personal administration from unconfirmed sources. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your health,” stated Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or authorized by any government authority globally. “Consequently at this time no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet authorized … may subject patients to possibly serious health risks”.